- Home
- CBNK vs ALMS Comparison
CBNK vs ALMS Comparison
Compare CBNK & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBNK
- ALMS
- Stock Information
- Founded
- CBNK 1974
- ALMS 2021
- Country
- CBNK United States
- ALMS United States
- Employees
- CBNK N/A
- ALMS N/A
- Industry
- CBNK Major Banks
- ALMS
- Sector
- CBNK Finance
- ALMS
- Exchange
- CBNK Nasdaq
- ALMS NYSE
- Market Cap
- CBNK 462.4M
- ALMS 469.0M
- IPO Year
- CBNK 2018
- ALMS 2024
- Fundamental
- Price
- CBNK $29.07
- ALMS $7.66
- Analyst Decision
- CBNK Hold
- ALMS Strong Buy
- Analyst Count
- CBNK 1
- ALMS 6
- Target Price
- CBNK $32.00
- ALMS $29.60
- AVG Volume (30 Days)
- CBNK 59.7K
- ALMS 122.0K
- Earning Date
- CBNK 01-28-2025
- ALMS 02-15-2025
- Dividend Yield
- CBNK 1.38%
- ALMS N/A
- EPS Growth
- CBNK N/A
- ALMS N/A
- EPS
- CBNK 2.33
- ALMS N/A
- Revenue
- CBNK $157,884,000.00
- ALMS N/A
- Revenue This Year
- CBNK N/A
- ALMS N/A
- Revenue Next Year
- CBNK $28.67
- ALMS N/A
- P/E Ratio
- CBNK $12.45
- ALMS N/A
- Revenue Growth
- CBNK 0.41
- ALMS N/A
- 52 Week Low
- CBNK $19.02
- ALMS $6.75
- 52 Week High
- CBNK $31.22
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- CBNK 57.32
- ALMS N/A
- Support Level
- CBNK $26.49
- ALMS N/A
- Resistance Level
- CBNK $28.28
- ALMS N/A
- Average True Range (ATR)
- CBNK 0.62
- ALMS 0.00
- MACD
- CBNK 0.05
- ALMS 0.00
- Stochastic Oscillator
- CBNK 100.00
- ALMS 0.00
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, Corporate Office, and OpenSky. Its Commercial Banking division offers banking-related services to clients, Capital Bank Home Loans division offers conventional and government-guaranteed residential mortgage loans on a nationwide basis for sale into the secondary market, while its OpenSky division provides secured credit cards on a nationwide basis to under-banked populations and those looking to rebuild their credit scores.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.